Roche's fat-burning drug shows promise for diabetes

12/14/2011 | Bloomberg

Roche Holding's experimental fat-burning drug helped lower blood glucose levels for 30 days and induce a 10% weight reduction in mice with diabetes, a study in Science Translational Medicine revealed. The drug also helped activate calorie-burning brown fats, increase energy spending and decrease liver fat, researchers said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI